학술논문
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma
Document Type
Article
Author
Klausen, U.; Grønne Dahlager Jørgensen, N.; Novotny, G.W.; Pedersen, L.M.; Gang, A.O.; Pedersen, L.B.; Niemann, C.U.; Grauslund, J.H.; Munir Ahmad, S.; Martinenaite, E.; Weis-Banke, S.E.; Kjeldsen, J.W.; Orebo Holmström, M.; Met, Ö.; Svane, I.M.; Andersen, M.H.; Breinholt, M.F.; Poulsen, C.B.; Hansen, P.B.
Source
In: OncoImmunology . (OncoImmunology, 2021, 10(1))
Subject
Language
English
ISSN
2162402X
21624011
21624011